Literature DB >> 32748270

Laparoscopic hepatectomy enhances recovery for small hepatocellular carcinoma with liver cirrhosis by postoperative inflammatory response attenuation: a propensity score matching analysis with a conventional open approach.

Xiu-Tao Fu1, Zheng Tang1, Jia-Feng Chen1, Ying-Hong Shi1, Wei-Ren Liu1, Qiang Gao1, Guang-Yu Ding1, Kang Song1, Xiao-Ying Wang2, Jian Zhou1,3, Jia Fan4,5, Zhen-Bin Ding6.   

Abstract

BACKGROUND: The concurrent presence of liver cirrhosis and hepatocellular carcinoma (HCC) poses a challenge for laparoscopic surgeons to establish a routine practice. The aim of this study was to gather evidence and produce recommendations on the safe and effective practice of laparoscopic hepatectomy for patients with solitary HCC (≤ 5 cm) and liver cirrhosis.
METHODS: Between October 2013 and October 2014, 356 curative hepatectomies were performed for patients pathologically diagnosed with solitary HCC (≤ 5 cm) accompanied by cirrhosis (stage 4 fibrosis). To overcome selection bias, a 1:2 match using propensity score matching analysis was conducted between laparoscopic and open hepatectomy. Perioperative outcomes were compared between the groups, including hospitalization, operation time, blood loss, and surgical complications. Perioperative inflammation-based markers, including systemic immune-inflammation index (SII), neutrophil-to-lymphocyte ratio (NLR), platelet-to-lymphocyte ratio (PLR), and lymphocyte-to-monocyte ratio (LMR) were collected from medical records and analyzed.
RESULTS: There were 43 and 77 patients in the laparoscopic and open groups, respectively. The laparoscopic group had less hepatic inflow occlusion (16.3% vs. 61%; P < 0.001), shorter operation time (155 vs. 170 min; P = 0.004), and shorter postoperative hospital stay (4 vs. 7 days; P < 0.001). Although the difference was not significant (P = 0.154), the rate of postoperative complications tended to be lower in the laparoscopic group (2.3%) compared with the open group (9.1%). The increase in postoperative SII, NLR, and LMR for laparoscopic hepatectomy were significantly lower than for open hepatectomy. NLR < 5.8 on postoperative day 3 was significantly correlated with shorter hospital stay (P < 0.001).
CONCLUSIONS: Compared with open hepatectomy, laparoscopic hepatectomy for selected HCC patients, even in the presence of cirrhosis, might result in better perioperative outcomes and postoperative inflammatory response attenuation, and ultimately promote faster recovery. This provides evidence for considering routine laparoscopic hepatectomy through careful selection of patients with HCC.

Entities:  

Keywords:  Hepatectomy; Hepatocellular carcinoma; Inflammatory response; Laparoscopy; Liver cirrhosis

Year:  2020        PMID: 32748270     DOI: 10.1007/s00464-020-07710-5

Source DB:  PubMed          Journal:  Surg Endosc        ISSN: 0930-2794            Impact factor:   4.584


  3 in total

Review 1.  Laparoscopic liver resection for hepatocellular carcinoma in patients with cirrhosis.

Authors:  Tan To Cheung; Chung Mau Lo
Journal:  Hepatobiliary Surg Nutr       Date:  2015-12       Impact factor: 7.293

2.  Problems of hepatectomy in cirrhosis.

Authors:  S T Fan
Journal:  Hepatogastroenterology       Date:  1998-08

3.  A Prospective Study of Altered Inflammatory Response and Its Clinical Outcome following Laparoscopic and Open Cholecystectomy.

Authors:  Sayyed Ehtesham Hussain Naqvi; Atia Zaka-Ur-Rab; Najmul Islam; Eram Ali
Journal:  Iran J Med Sci       Date:  2017-07
  3 in total
  2 in total

1.  Laparoscopic vs. Open Repeat Hepatectomy for Recurrent Liver Tumors: A Propensity Score-Matched Study and Meta-Analysis.

Authors:  Jia-Feng Chen; Xiu-Tao Fu; Zheng Gao; Ying-Hong Shi; Zheng Tang; Wei-Ren Liu; Xin Zhang; Qiang Gao; Guang-Yu Ding; Kang Song; Xiao-Ying Wang; Jian Zhou; Jia Fan; Zhen-Bin Ding
Journal:  Front Oncol       Date:  2021-04-22       Impact factor: 6.244

2.  Efficacy of Laparoscopic Hepatectomy versus Open Surgery for Hepatocellular Carcinoma With Cirrhosis: A Meta-analysis of Case-Matched Studies.

Authors:  Yu Pan; Shunjie Xia; Jiaqin Cai; Ke Chen; Xiujun Cai
Journal:  Front Oncol       Date:  2021-05-07       Impact factor: 6.244

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.